Comparative efficacy of topical anthralin and intralesional triamcinolone in the treatment of alopecia areata.
Saravu Rama Bhat Narahari
Abstract
Saravu Rama Bhat Narahari
Abstract
Efficacy of intralesional triamcinolone acetonide (10mg/ml) and topical anthralin 1.15% cream was compared in the treatment of alopecia areata. Study groups consisted of 37 patients for injection and 32 patients for cream. All of them belonged to Type I of Ikeda's classification. The study showed that triamcinolone induces more adequate response in terms of regrowth of hairs than anthralin. However, the relapse rate was higher with triamcinolone. No difference was noted in terms of complete regrowth of hairs on the lesional skin and side effects of drugs.
OpenAlex reports 7 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Efficacy of intralesional triamcinolone acetonide (10mg/ml) and topical anthralin 1.15% cream was compared in the treatment of alopecia areata. Study groups consisted of 37 patients for injection and 32 patients for cream. All of them belonged to Type I of Ikeda's classification. The study showed that triamcinolone induces more adequate response in terms of regrowth of hairs than anthralin. However, the relapse rate was higher with triamcinolone. No difference was noted in terms of complete regrowth of hairs on the lesional skin and side effects of drugs.
Key concepts: Triamcinolone acetonide, Alopecia areata, Dermatology, Medicine, Significant difference, Surgery, Internal medicine